JFG
SLS icon

Jefferies Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Jefferies Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
+200,459
New +$1.38M 0.02% 545
2026
Q1 		– Sell
-10,100
Closed -$38.1K – 2167
2025
Q4 		$38.1K Buy
+10,100
New +$19.6K ﹤0.01% 1777

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jefferies Financial Group's SLS Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 200,459 shares worth $2.96M. The stake represents 0.02% of the portfolio and ranks #545 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in SLS as recently as Q4 2025.

Jefferies Financial Group first reported a position in SLS in Q4 2025 and has held it in 2 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Jefferies Financial Group held 200,459 shares of SELLAS Life Sciences worth $2.96M as of Q2 2026.
  • SELLAS Life Sciences was a new Jefferies Financial Group position in Q2 2026.
  • SELLAS Life Sciences made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #545 holding.
  • Jefferies Financial Group first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.